Advertisement
JBC

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Originally published In Press as doi:10.1074/jbc.M201939200 on May 10, 2002

J. Biol. Chem., Vol. 277, Issue 29, 26194-26199, July 19, 2002
This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
277/29/26194    most recent
M201939200v1
Right arrow Submit a Letter to Editor
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Liu, X.
Right arrow Articles by Zweier, J. L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Liu, X.
Right arrow Articles by Zweier, J. L.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Nitric Oxide Uptake by Erythrocytes Is Primarily Limited by Extracellular Diffusion Not Membrane Resistance*

Xiaoping LiuDagger §, Alexandre SamouilovDagger , Jack R. Lancaster Jr., and Jay L. ZweierDagger

From the Dagger  Molecular and Cellular Biophysics Laboratories, Department of Medicine, Division of Cardiology and the Electron Paramagnetic Resonance Center, The Johns Hopkins University School of Medicine, Baltimore, Maryland 21224 and the  Departments of Physiology and Medicine, Louisiana State University Health Sciences Center, New Orleans, Louisiana 70112

Received for publication, February 26, 2002, and in revised form, May 1, 2002

    ABSTRACT
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES

The process of NO transfer into erythrocytes (RBCs) is of critical biological importance because it regulates the bioavailability and diffusional distance of endothelial-derived NO. It has been reported that the rate of NO reaction with oxyhemoglobin (Hb) within RBCs is nearly three orders of magnitude slower than that by equal amounts of free oxyhemoglobin. Consistent with early studies on oxygen uptake by RBCs, the process of extracellular diffusion was reported to explain this much lower NO uptake by RBC encapsulated Hb (Liu, X., Miller, M. J., Joshi, M. S., Sadowska-Krowicka, H., Clark, D. A., and Lancaster, J. R., Jr. (1998) J. Biol. Chem. 273, 18709-18713). However, it was subsequently proposed that the RBC membrane provides the main resistance to NO uptake rather than the process of extracellular diffusion (Vaughn, M. W., Huang, K. T., Kuo, L., and Liao, J. C. (2000) J. Biol. Chem. 275, 2342-2348). This conclusion was based on competition experiments that were assumed to be able to determine the rate constant of NO uptake by RBCs without extracelluar diffusion limitation. To test the validity of this hypothesis, we theoretically analyzed competition experiments. Here, we show that competition experiments do not eliminate the extracellular diffusion limitation. Simulation of the competition data indicates that the main resistance to NO uptake by RBCs is caused by extracellular diffusion in the unstirred layer surrounding each RBC but not by the RBC membrane. This extracellular diffusion resistance is responsible for preventing interference of NO signaling in the endothelium without the need for special NO uptake by intracellular hemoglobin or a unique membrane resistance mechanism.

    INTRODUCTION
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES

Nitric oxide (nitrogen monoxide, NO) has been recognized as a critical physiological mediator in the regulation of vascular tone (1). It is generated in vascular endothelium by a specific arginine-dependent NO synthase, NOS3. Free diffusion has been considered to be the main process that determines how NO travels from the site of its formation to target sites where it exerts its critical physiological functions (2, 3).

In the vascular lumen NO can be scavenged by hemoglobin subunits (Hb)1 within RBCs. The reaction of NO with myoglobin and hemoglobin is rapid (bimolecular rate constant for oxyMb is kMb = 3 × 107 M-1 s-1 and for oxyHb is kHb = 6-9 × 107 M-1 s-1) (4, 5). It has been reported that 10 µM cell-free Hb is enough to trap almost all NO production generated from endothelial cells and abolish NO-mediated vasodilation (6, 7), while blood contains about 8 mM Hb, which is much higher than the quantity of Hb required to completely eliminate NO-mediated functional effects. The rapid reaction between NO and oxyhemoglobin raises the question of how NO can escape from the large quantity of Hb in the blood vessel lumen to exert physiological effects in the blood vessel wall after it is generated from endothelial cells (2, 8). This has led to recent efforts to understand and theoretically model the reaction process between NO and Hb (9-12).

It was observed that the rate of NO reaction with RBC-enclosed Hb is nearly three orders of magnitude slower than the rate of NO reaction with free Hb (9). Based on a diffusion-limited reaction model where the limiting step for NO reaction with RBC-enclosed Hb is diffusion of NO from the solution to the surface of RBCs, it was found that the calculated rate constant for the reaction between NO and RBC Hb is very close to that experimentally determined with direct electrochemical measurements. Recently, these experimental results were verified in competition experiments comparing the scavenging of NO by free Hb to that of RBC-enclosed Hb (13); however, it was concluded that the RBC membrane is the main resistance to NO transfer into RBCs. This was based on the following competition Equation 1, which was derived under the assumption that much of extracellular diffusion resistance is eliminated in competition experiments because NO is uniformly generated in extracellular solution, and a high hematocrit (>5%) was used in the experiments (13, 14).
([<UP>metHb</UP>]<SUB>c</SUB>−(1−<UP>Hct</UP>)[<UP>metHb</UP>]<SUB>ex</SUB>)/[<UP>Hb</UP>]<SUB>RBC</SUB> (Eq. 1)

=(k<SUB><UP>RBC</UP></SUB>/k<SUB><UP>Hb</UP></SUB>)<UP>ln</UP>([<UP>Hb</UP>]<SUP>0</SUP><SUB>ex</SUB>/[<UP>Hb</UP>]<SUB>ex</SUB>)
[metHb]c is the metHb concentration in the cell-free control, [metHb]ex is the extracellular metHb concentration, [Hb]RBC is defined as the RBC-enclosed Hb concentration in solution if all the RBCs were lysed, [Hb]ex is extracellular Hb concentration, and [Hb]<UP><SUB><IT>ex</IT></SUB><SUP><IT>o</IT></SUP></UP> is the initial [Hb]<UP><SUB><IT>ex</IT></SUB><SUP><IT>o</IT></SUP></UP>. kRBC and kHb are rate constants of the NO reaction with RBCs and free Hb, respectively. [metHb]ex is measured experimentally and then the ratio of kRBC/kHb is determined from Equation 1 using these experimental data. It was found that the ratio of kRBC/kHb has a large increase as hematocrit changes from 1.6 to 5%, and then the ratio slightly increases as hematocrit changes from 5 to 16%. The large increase of kRBC as hematocrit changes from 1.6 to 5% was attributed to the diminution of extracellular diffusion resistance, and therefore the value of kRBC, measured in the high hematocrit region, was considered to be caused only by RBC membrane resistance.

The controversy about the resistance of RBCs to NO transfer is analogous to that relating to explanations for RBC oxygen uptake. More than 70 years ago, it was discovered that RBC oxygen uptake was considerably slower than that of an equivalent concentration of free Hb (15). Early investigators suggested that oxygen uptake by RBCs is limited mainly by the transport of oxygen across the RBC membrane and intracellular diffusion of oxygen based on the assumption that extracellular oxygen gradients are not present in rapid mixing devices (16, 17). However, it is now accepted that effective diffusion layers around RBCs still exist in rapid mixing devices (18, 19) and are mainly responsible for the resistance of RBC oxygen transfer (18-23).

Since the assumption of competition experiments was not based on strict theoretical analysis, one may ask the following two questions. 1) Is NO concentration really uniformly distributed in solution in the competition experiments? 2) Does the value of kRBC at high hematocrit (from 5 to 16%) really represent the rate constant of transmembrane diffusion? To answer the two questions, we have theoretically analyzed competition experiments in this study. NO concentration, NO flux at RBC membrane, the formation rate of extracellular metHb, and the ratio of kRBC/kHb are calculated and shown at different membrane permeabilities (Pm) and hematocrits (Hct). Our results show that NO concentration is not uniform in solution in competition experiments. Computer simulation of competition data indicates that RBC NO uptake is primarily limited by the extracellular diffusion resistance rather than the RBC membrane resistance.

    MATERIALS AND METHODS
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES

Model Assumptions-- The disc shape of RBC is replaced with a spherical shape for simplifying the theoretical analysis. The effective radius of the spherical RBC, r0, is determined from the surface area of the disc shape (14). In this model, the spherical RBC is fixed at the center of a limited spherical volume or container with a radius r1. The radius of the container is defined by the hematocrit as the ratio of the RBC volume to the container volume,r<UP><SUB>0</SUB><SUP>3</SUP></UP>/ r<UP><SUB>1</SUB><SUP>3</SUP></UP>. For the competition experiments, the RBC is surrounded with Hb solution that fills the space between the surface of the RBC and the inner wall of the container (Fig. 1). After adding an NO donor to the extracellular Hb solution, the donor uniformly distributes in the whole extracellular solution. NO released from the donor either reacts with Hb in the extracellular solution to form metHb or transfers into the RBC. NO that enters into the RBC is immediately scavenged by the concentrated intracellular Hb so that NO concentration inside the RBC is maintained very close to zero. Since NO is slowly released from the NO donor and extracellular Hb concentration is much greater than NO concentration in competition experiments, the extracellular Hb can be considered to be homogeneously distributed in the solution. With these assumptions we have analytically derived expressions to predict extracellular NO concentration, NO flux at the RBC membrane, the formation rate of extracellular metHb, and the ratio of kRBC/kHb.


View larger version (50K):
[in this window]
[in a new window]
 
Fig. 1.   Diagram illustrating the competition model of the NO reaction with free and RBC Hb. A spherical container of radius r1 is filled with free extracellular Hb solution, and a Hb-containing RBC with radius r0 is fixed at the center of the container. The radius r1 is determined by the Hct from the equation Hct = (r0/r1)3.

Mathematical Analysis of Diffusion in Competition Experiments-- Based on the above assumptions, the following diffusion-reaction equation and boundary conditions (Equations 2-4) are used to describe the competition experiment for any hematocrit (from 0 to 100%),


<UP>D</UP><SUB><UP>NO</UP></SUB> <FR><NU>1</NU><DE>r<SUP>2</SUP></DE></FR> <FR><NU>d</NU><DE>dr</DE></FR><FENCE>r<SUP>2</SUP> <FR><NU>d[<UP>NO</UP>]</NU><DE>dr</DE></FR></FENCE>+k<SUB>1</SUB>[<UP>A</UP>]−k<SUB><UP>Hb</UP></SUB>[<UP>Hb</UP>]<SUB>ex</SUB>[<UP>NO</UP>]=0 (Eq. 2)

<UP>D</UP><SUB><UP>NO</UP></SUB>d[<UP>NO</UP>]/dr=<UP>P<SUB>m</SUB></UP>[<UP>NO</UP>]<SUP><UP>m</UP></SUP> <UP>at</UP> r=<UP>r</UP><SUB>0</SUB> (Eq. 3)

d[<UP>NO</UP>]/dr=0 <UP>at</UP> r=<UP>r</UP><SUB>1</SUB> (Eq. 4)
where DNO is the diffusion constant of NO in the extracellular solution; Pm is membrane permeability; k1, kHb are the rate constants of decomposition of the NO donor and the NO reaction with Hb, respectively; [A], [NO], [NO]m are NO donor concentration, NO concentration in solution, and NO concentration on the outer surface of the RBC, respectively; [Hb]ex is extracellular Hb concentration; and r0 and r1 are radii of the RBC and the spherical container as shown in Fig. 1, respectively. In solution, the change of NO concentration at any location between r = r0 and r = r1 can be caused by NO diffusion, NO generation, and NO consumption at that location, which is expressed by the first, second, and third terms in Equation 2. At the boundary r = r0, the diffusion rate of NO into the RBC surface should be equal to the rate of NO transfer across the RBC membrane, so we have Equation 3. At the boundary r = r1, there is no net NO flow into or out from the container surface, so the gradient of NO concentration at r = r1 should be equal to zero as expressed in Equation 4.

Computer Simulations-- All simulated curves in this study were calculated from the analytical expressions derived in the next section on a pentium III personal computer with QBasic programs.

    RESULTS
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES

The Effect of Hematocrit on NO Concentration Distribution-- To test if increasing hematocrit can change the NO concentration distribution from inhomogeneous to homogeneous, we directly solved the diffusion-reaction Equation 2 and their boundary conditions, Equations 3 and 4.

Assuming that [A] and [Hb]ex are uniform in the solution during the competition experiment, the general solution for Equation 2 can be expressed as Equation 5,
[<UP>NO</UP>]=<FR><NU>k<SUB>1</SUB>[<UP>A</UP>]</NU><DE>k<SUB><UP>Hb</UP></SUB>[<UP>Hb</UP>]<SUB>ex</SUB></DE></FR>+<FR><NU>1</NU><DE>r</DE></FR>[<UP>a · exp</UP>(<UP>−</UP>f<UP>r</UP>)+<UP>b · exp</UP>(f<UP>r</UP>)] (Eq. 5)
where
f=<RAD><RCD>k<SUB><UP>Hb</UP></SUB>[<UP>Hb</UP>]<SUB>ex</SUB>/<UP>D</UP><SUB><UP>NO</UP></SUB></RCD></RAD> (Eq. 6)
and constants a and b can be determined by boundary conditions in Equations 3 and 4. Equation 5 is true for [Hb]ex > 0 or for k1[A]/kHb[Hb]ex = constant as [Hb]ex approaches zero. In competition experiments, we have [Hb]ex > 0.

The combination of Equation 5 with Equations 3 and 4 give us Equation 7,
   [<UP>NO</UP>]=[<UP>NO</UP>]<SUP><UP>b</UP></SUP><FENCE>1−<FR><NU><UP>P<SUB>m</SUB>r</UP><SUP>2</SUP><SUB>0</SUB>[(f<UP>r</UP><SUB>1</SUB>−1)&PHgr;(<UP>r</UP>)+(f<UP>r</UP><SUB>1</SUB>+1)/&PHgr;(<UP>r</UP>)]</NU><DE><UP>D</UP><SUB><UP>NO</UP></SUB>r<UP>Y</UP>(f, <UP>r</UP><SUB>1</SUB>, <UP>r</UP><SUB>0</SUB>)</DE></FR></FENCE> (Eq. 7)
where [NO]b is the NO concentration in solution in the absence of RBCs,
[<UP>NO</UP>]<SUP>b</SUP>=k<SUB>1</SUB>[<UP>A</UP>]/k<SUB><UP>Hb</UP></SUB>[<UP>Hb</UP>]<SUB>ex</SUB> (Eq. 8)

<UP>Y</UP>(f, <UP>r</UP><SUB>1</SUB>, <UP>r</UP><SUB>0</SUB>)=(fr<SUB>1</SUB>−1)(fr<SUB>0</SUB>+1+<UP>P<SUB>m</SUB>r</UP><SUB>0</SUB>/<UP>D</UP><SUB><UP>NO</UP></SUB>)&PHgr;(<UP>r</UP><SUB>0</SUB>) (Eq. 9)

−(fr<SUB>1</SUB>+1)(fr<SUB>0</SUB>−1−<UP>P<SUB>m</SUB>r</UP><SUB>0</SUB>/<UP>D</UP><SUB><UP>NO</UP></SUB>)/&PHgr;(<UP>r</UP><SUB>0</SUB>)

&PHgr;(r)=<UP>exp</UP>[f(<UP>r</UP><SUB>1</SUB>−r)] (Eq. 10a)
and
&PHgr;(<UP>r</UP><SUB>0</SUB>)=<UP>exp</UP>[f(<UP>r</UP><SUB>1</SUB>−<UP>r</UP><SUB>0</SUB>)] (Eq. 10b)
according to the definition of hematocrit, Hct = r<UP><SUB>0</SUB><SUP>3</SUP></UP>/ r<UP><SUB>1</SUB><SUP>3</SUP></UP>, we can replace r1 with Hct in Equation 7. NO concentration distribution profiles around the RBC for different Pm and Hct values are shown in Fig. 2, A and B. In the simulations, we used [Hb]ex = 10 µM, kHb = 89 µM-1 s-1 (20 °C) (5), DNO = 2600 µm2/s (25 °C) (24). Since the molar volume of NO is close to the molar volume of oxygen, their diffusion constant would be similar (25). The diffusion constant of oxygen in solution at 25 °C is 2420 µm2/s (26); therefore, it is reasonable to take the value of DNO = 2600 µm2/s as the NO diffusion constant at 25 °C. In competition experiments, it was assumed that when hematocrit was smaller then 5%, the extracellular diffusion resistance becomes significant as hematocrit decreases, but kRBC calculated from the competition equation did not include any extracellular diffusion resistance as the hematocrit was greater than 10% (13). The profiles of NO concentration that were drawn according to the assumption for competition experiments are shown in Fig. 2C. In this assumption, the NO concentration distribution in the diffusion layer must have a large change to eliminate the inhomogeneous NO concentration distribution as hematocrit increases from 0.2 to 5%.


View larger version (16K):
[in this window]
[in a new window]
 
Fig. 2.   Graph of the relative NO concentration, [NO]/[NO]b versus the distance from the RBC membrane (r - r0). Parameters used in the calculation are kHb = 89 µm/s, DNO = 2600 µm2/s, r0 = 3.39 µm, [Hb]ex = 10 µM, intracellular Hb concentration cRBC = 2200 µM, Pm = 0.9 m/s (A), and Pm = 1.8 × 10-3 m/s (B). Arrows designate the location of inner surface of the container at each relative hematocrit. In C, curves of NO concentration are drawn according to the assumption for competition experiments for three different hematocrits: Hct = 0.2% (solid line), Hct = 5% (dots), and 10% (dash).

The Effect of Hematocrit on the Flux of NO Transfer into RBCs-- In order to further test how hematocrit affects the extracellular diffusion resistance, we derived the analytical expression for the flux of NO transfer into RBCs and analyzed how the flux varies with hematocrit. If the flux largely increases with hematocrit or the extracellular diffusion resistance largely decreases with hematocrit, then membrane resistance may become the limiting step to NO transfer into RBCs.

The flux of NO diffusion into the RBC is given by Equation 11,
  <UP>F</UP><SUB><UP>in</UP></SUB>=<UP>D</UP><SUB><UP>NO</UP></SUB>d[<UP>NO</UP>]/dr‖<SUB>r=<UP>r</UP><SUB>0</SUB></SUB>=<UP>P<SUB>m</SUB></UP>[<UP>NO</UP>]<SUP><UP>m</UP></SUP>=<UP>P<SUB>m</SUB></UP>k<SUB>1</SUB>[<UP>A</UP>]&PSgr;/k<SUB><UP>Hb</UP></SUB>[<UP>Hb</UP>]<SUB>ex</SUB> (Eq. 11)
where
&PSgr;=<FR><NU>(f<UP>r</UP><SUB>1</SUB>−1)(f<UP>r</UP><SUB>0</SUB>+1)&PHgr;(<UP>r</UP><SUB>0</SUB>)−(f<UP>r</UP><SUB>1</SUB>+1)(f<UP>r</UP><SUB>0</SUB>−1)/&PHgr;(<UP>r</UP><SUB>0</SUB>)</NU><DE><UP>Y</UP>(f, <UP>r</UP><SUB>1</SUB>, <UP>r</UP><SUB>0</SUB>)</DE></FR> (Eq. 12)
In competition experiments, NO donor or NO is used as a probe to measure the ratio of kRBC/kHb. It is assumed that the physical properties of the RBC membrane and solution diffusion resistances are independent of [NO] or NO donor concentration [A]. In Equation 11, Fin is proportional to [A], so we use Fn = 3Fin/k1[A]r0 to obtain a [NO]-independent flux. Fn is proportional to Fin but independent of NO donor concentration [A]. The first derivative of Fn with respect to r1 can be derived from Equation 11 and is shown in Equation 13.
   d<UP>F</UP><SUB><UP>n</UP></SUB>/d<UP>r</UP><SUB>1</SUB>=12[f<SUP>2</SUP><UP>P<SUB>m</SUB>r</UP><SUB>0</SUB><UP>r</UP><SUB>1</SUB>/<UP>Y</UP>(f, <UP>r</UP><SUB>1</SUB>, <UP>r</UP><SUB>0</SUB>)]<SUP>2</SUP>/(k<SUB><UP>Hb</UP></SUB>[<UP>Hb</UP>]<SUB>ex</SUB><UP>r</UP><SUB>0</SUB><UP>D</UP><SUB><UP>NO</UP></SUB>)>0 (Eq. 13)
Since dFn/dr1 is always larger than zero, Fn will increase as r1 increases and decrease as r1 decreases. Fn will decrease as Hct increases because r1 is inversely proportional to Hct1/3 (Fig. 3). No matter whether the membrane permeability Pm is as high as 0.9 m/s or as low as 0.0018 m/s, Fn always decreases with the increase of Hct. Since Fn does not increase as hematocrit changes from 0 to 5%, extracellular diffusion resistance cannot be appreciably reduced by increasing the hematocrit.


View larger version (12K):
[in this window]
[in a new window]
 
Fig. 3.   Calculated initial fluxes of NO transfer into RBCs. The initial fluxes of NO on the surface of the RBC versus hematocrit as Pm = 0.9 m/s (a) and Pm = 1.8 × 10-3 m/s (b). Other parameters used in the calculations are kHb = 89 µM-1 s-1, DNO = 2600 µm 2/s, r0 = 3.39 µm, cRBC = 22000 µM, and [Hb]ex = 10 µM.

Expressions for the Formation Rate of Extracellular metHb Concentration and the Ratio of kRBC/kHb-- It is easy to prove that Equation 1 can be derived from the following two rate equations shown in Equations 14a and 14b,


d[<UP>metHb</UP>]<SUB>ex</SUB>/dt=k<SUB><UP>Hb</UP></SUB>[<UP>Hb</UP>]<SUB>ex</SUB>[<UP>NO</UP>] (Eq. 14a)

d[<UP>metHb</UP>]<SUB>RBC</SUB>/dt=k<SUB>RBC</SUB>[<UP>Hb</UP>]<SUB>RBC</SUB>[<UP>NO</UP>] (Eq. 14b)
where [metHb]RBC is defined as the RBC-enclosed metHb in solution if all the RBCs were lysed and [NO] is the extracellular NO concentration. [Hb]RBC can be calculated from hematocrit by Equation 15.
[<UP>Hb</UP>]<SUB>RBC</SUB>=<UP>c</UP><SUB>RBC</SUB><UP>Hct</UP>=<UP>c</UP><SUB>RBC</SUB><UP>r</UP><SUP>3</SUP><SUB>0</SUB>/<UP>r</UP><SUP>3</SUP><SUB>1</SUB> (Eq. 15)
Considering that [metHb]RBC is defined in the whole space within the spherical container, we have Equation 16,
d[<UP>metHb</UP>]<SUB>RBC</SUB>/dt=<UP>SF</UP><SUB><UP>in</UP></SUB>/<UP>V</UP><SUB><UP>T</UP></SUB>=3<UP>r</UP><SUP>2</SUP><SUB>0</SUB><UP>F</UP><SUB><UP>in</UP></SUB>/<UP>r</UP><SUP>3</SUP><SUB>1</SUB> (Eq. 16)
where the surface area of the RBC S is 4pi r<UP><SUB>0</SUB><SUP>2</SUP></UP> and the volume of the spherical container VT is 4pi r<UP><SUB>1</SUB><SUP>3</SUP></UP>/3. Considering that [metHb]ex is defined in the extracellular solution, we can obtain the formation rate of metHb in extracellular solution in Equation 17.
    d[<UP>metHb</UP>]<SUB>ex</SUB>/dt=k<SUB>1</SUB>[<UP>A</UP>]{1−3<UP>r</UP><SUP>2</SUP><SUB>0</SUB><UP>P<SUB>m</SUB></UP>&PSgr;/k<SUB><UP>Hb</UP></SUB>[<UP>Hb</UP>]<SUB>ex</SUB>(<UP>r</UP><SUP>3</SUP><SUB>1</SUB>−<UP>r</UP><SUP>3</SUP><SUB>0</SUB>)} (Eq. 17)
The time course of [metHb]ex can be obtained from Equation 17 using numerical integration methods. We compared [metHb]ex predicted from Equation 17 with the published experimental data in Fig. 4. The points in Fig. 4, A-C were read from Fig. 2(a), Fig. 4(a), and Fig. 5(a) in Ref. 13, respectively. Solid curves were calculated from Equation 17. Parameters used in the calculations are chosen as DNO = 2600 µm2/s and Pm = 0.9 m/s. Since kHb = 89 µM-1 s-1 was measured at 20 °C (5), we have extrapolated this value with a temperature coefficient of 1.4 per 10 °C that was used in estimating rate constants for the reaction of NO or CO with deoxyHb (27). Thus we obtained kHb = 105 µM-1 s-1 at 25 °C. The extrapolated value of kHb was then used in calculating the curves in Fig. 4. Other experimental parameters, such as initial extracellular Hb concentration, initial NO donor concentration, and hematocrit, were the same as those used in the competition experiments of Vaughn et al. (13).


View larger version (14K):
[in this window]
[in a new window]
 
Fig. 4.   Simulations of [metHb]ex versus time for different values of hematocrit, initial extracellular Hb concentration, and initial NO donor concentration. All curves of [metHb]ex (solid line) were calculated from Equation 17 with DNO = 2600 µm2 s-1, kHb = 105 µM-1 s-1, Pm = 0.9 m/s, and r0 = 3.39 µm. Other experimental parameters such as hematocrit, initial extracellular Hb concentration [Hb]<UP><SUB>ex</SUB><SUP>0</SUP></UP> and initial NO donor concentration are the same as those for each set of experimental data. Experimental data in panel A ( [Hb]<UP><SUB><IT>ex</IT></SUB><SUP>0</SUP></UP> = 7.5 µM, [A]0 = 10/(1-Hct) µM), shown as closed circles (Hct = 0%) and open circles (Hct = 7.8%), were read from Fig. 2. Experimental data in panel B (Hct = 15.6%, [A]0 = 10/(1-Hct) µM), represented by closed circles ([Hb]<UP><SUB><IT>ex</IT></SUB><SUP>0</SUP></UP> = 40 µM) and open circles ( [Hb]<UP><SUB><IT>ex</IT></SUB><SUP>0</SUP></UP> = 10 µM), were read from Fig. 4 of Ref. 13. Experimental data in panel C (Hct = 15.6%, [Hb]<UP><SUB><IT>ex</IT></SUB><SUP>0</SUP></UP> = 10 µM), shown as closed circles ([A]0 = 15/(1 - Hct) µM), open circles ([A]0 = 10/(1 - Hct) µM), and closed triangles ([A]0 = 5/(1 - Hct) µM) were read from Fig. 5 (curve a) of Ref. 13.

The expression for the ratio kRBC/kHb can be obtained by a combination of Equations 14a, 14b, and 15 with Equations 16 and 17 as shown in Equation 18.
<FR><NU>k<SUB>RBC</SUB></NU><DE>k<SUB><UP>Hb</UP></SUB></DE></FR>=<FR><NU>[<UP>Hb</UP>]<SUB>ex</SUB>d[<UP>metHb</UP>]<SUB>RBC</SUB>/dt</NU><DE>[<UP>Hb</UP>]<SUB>RBC</SUB>d[<UP>metHb</UP>]<SUB>ex</SUB>/dt</DE></FR>=<FR><NU>3<UP>P<SUB>m</SUB></UP>(1−<UP>Hct</UP>)&PSgr;/k<SUB><UP>Hb</UP></SUB>c<SUB>RBC</SUB><UP>r</UP><SUB>0</SUB></NU><DE>1−<UP>Hct</UP>(1+3<UP>P<SUB>m</SUB></UP>&PSgr;/k<SUB><UP>Hb</UP></SUB>[<UP>Hb</UP>]<SUB>ex</SUB><UP>r</UP><SUB>0</SUB>)</DE></FR> (Eq. 18)
In Equation 18, [Hb]ex decreases with time in a competition experiment. If [Hb]ex at time t is known, one can find the ratio of kRBC/kHb from the equation at time t. In Fig. 5, we compared the predicted curves from Equation 18 with the experimental data. These experimental data were read from Fig. 3b of Vaughn et al. (13), and the two curves of kRBC/kHb versus hematocrit were calculated from Equation 18 as Pm = 0.9 m/s (a) and Pm = 4.15 × 10-4 m/s (b). In calculations, we chose DNO = 2600 µm2/s, kHb = 105 µM-1 s-1, which were the same as those used in Fig. 4. The competition experiments were performed with 9 µM (Hct > 4%) or 2 µM (Hct < 4%) of initial extracellular Hb concentration (13). During competition experiments, [Hb]ex was slowly consumed by the reaction with NO. From Fig. 2a in Ref. 13 we know that the maximum value of ln([Hb]<UP><SUB>ex</SUB><SUP>0</SUP></UP>/[Hb]ex) in a competition experiment is about 1.3, so [Hb]ex at the end of a competition experiment could be as low as 2.5 µM if ([Hb]<UP><SUB>ex</SUB><SUP>0</SUP></UP> = 9 µM or 0.5 µM if ([Hb]<UP><SUB>ex</SUB><SUP>0</SUP></UP> = 2 µM. Thus, the average [Hb]ex is chosen as 5 µM in our calculations. Fig. 5 shows that the experimental data are in good agreement with curve a, which was calculated under the assumption of extracellular diffusion limitation (Pm = 0.9 m/s). However, curve b calculated under the assumption of membrane resistance limitation (Pm = 4.15 × 10-4 m/s) is very different from the experimental data.


View larger version (14K):
[in this window]
[in a new window]
 
Fig. 5.   Plot of kRBC/kHb versus hematocrit. Experimental data (closed circles) were read from Fig. 3 (curve b) of Ref. 13. Curves (solid lines) were calculated from Equation 18. Parameters used in the calculation are kHb = 105 µM-1 s-1, r0 = 3.39 µm, DNO = 2600 µm2/s, [Hb]ex = 5 µM, Pm = 0.9 m/s (curve a) and Pm = 4.15 × 10-4 m/s (curve b).


    DISCUSSION
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES

Our model predicts that the NO concentration at the RBC surface, [NO]m, is close to zero if Pm = 0.9 m/s, a value reported by Subczynski et al. (28) for lipid bilayer membrane. In this case, NO uptake by RBCs would be limited by extracellular diffusion (Fig. 2A). At Hct = 0.2%, the distance between the RBC surface to the inner wall of the container, r1 - r0, is about 23.5 µm. There is a layer with a big NO concentration gradient (r - r 0 < 6 µm) near the RBC, and a region of uniform NO concentration outside the concentration gradient layer between r - r 0 = 6 µm and r - r 0 = 23.5 µm. The radius of the container r1 decreases with the increase of hematocrit. As Hct = 5%, (r1 - r 0) is reduced to 5.8 µm, and the region of uniform NO concentration disappears. However, the inhomogeneous NO concentration distribution within the concentration gradient layer almost remains unchanged. Thus, in contrast to the assumption of the competition experiments, increasing hematocrit from 0.2 to 5% does not make NO concentration distribution more homogeneous; rather NO concentration distribution is more inhomogeneous. Further increasing hematocrit from 5 to 10% has little effect on the NO concentration gradient near the RBC surface. NO uptake by the RBC is still limited by extracellular diffusion because [NO]m is still close to zero compared with the NO concentration at the inner surface of the container, [NO]c. Fig. 2B shows the profile of NO concentration as the RBC membrane is 500 times lower, or Pm = 1.8 × 10-3 m/s. Similar to Pm = 0.9 m/s, the NO concentration distribution in solution as Pm = 1.8 × 10-3 m/s is more inhomogeneous, not more homogeneous, as hematocrit increases from 0.2 to 5%. At Hct = 10%, the big NO concentration gradient still exists between the RBC surface and the inner wall of the container. Simply speaking, Fig. 2, A and B show that changing hematocrit from 1.6 to 10% has little effect on extracellular diffusion resistance no matter if Pm is high or low. However, the original assumption of competition experiments (Fig. 2C), which predicts a complete conversion of inhomogeneous NO concentration distribution into homogeneous NO concentration distribution is in conflict with those predicted by the diffusion-reaction equation (Fig. 2, A and B). Therefore, there is no theoretical basis from which to claim that kRBC determined around Hct = 10% does not include any extracellular diffusion resistance.

In fact, there is evidence in the literature for an external diffusional limitation for other small nonelectrolytes, such as O2 and CO (29, 18) across the erythrocyte membrane. Vandegriff and Olson (30) demonstrated that the rate of O2 uptake by erythrocytes is inversely proportional to the size of RBC (using erythrocytes from various species as well as liposome-entrapped hemoglobin), a result directly predicted by the existence of an unstirred layer (9, 30) and not predicted on the basis of an inherent diffusion barrier (9, 30). Since NO and O2 have similar size and solubility, the permeability of RBC membrane to the two small neutral molecules should be similar. In a previous study, we showed that NO uptake by RBCs at a low hematocrit is limited by extracellular diffusion (9). Vaughn et al. (13) also demonstrated that extracellular diffusion is the main resistance to NO uptake by RBCs as Hct = 1.6% in competition experiments. The above theoretical analysis (refer to Fig. 2A) shows that if NO uptake by RBCs is limited by extracellular diffusion resistance at low hematocrit, the extracellular diffusion resistance would have little change by increasing hematocrit from 0.2 to 10%. Thus NO uptake by RBCs in competition experiments of Vaughn et al. (13) would still be limited by extracellular diffusion resistance.

Fig. 4 shows that if NO uptake by RBCs is limited by extracellular diffusion, or Pm = 0.9 m/s, the calculated curves of [metHb]ex at different sets of hematocrit, [Hb]ex and NO donor concentration are in good agreement with experimental data. As shown in Fig. 5, the experimentally determined ratios of kRBC/kHb, except the one as Hct = 1.6%, are very close to curve a (Pm = 0.9 m/s), indicating that extracellular diffusion is the main resistance to NO uptake by RBCs. The experimentally determined ratio of kRBC/kHb as Hct = 1.6% largely deviates from curve a. This large deviation is caused by a low initial [Hb]ex (2 µM) that was used in the experiment as Hct = 1.6%, because this low [Hb]ex can result in a low ratio of kRBC/kHb and may cause a larger relative error in an experimental measurement of [metHb]ex. If we let Pm = 4.15 × 1 0-4 m/s, a very low membrane permeability suggested by Vaughn et al. (14), the simulated curve (curve b) is much lower than the reported ratios of kRBC/kHb.

The analysis above shows that the rate of NO uptake by RBCs is primarily limited by extracellular NO diffusion in the competition experiments. Mathematically, as long as a non-zero diffusion flux exists around a RBC, the diffusion flux can be always related to a diffusion layer as shown in Equation 19,
<UP>Flux</UP>=<UP>D</UP> <FR><NU>dc</NU><DE>dr</DE></FR>=<UP>D</UP> <FR><NU><UP>c</UP><SUP><UP>b</UP></SUP>−<UP>c</UP><SUP><UP>s</UP></SUP></NU><DE>&dgr;</DE></FR> <UP>at</UP> r=<UP>r</UP><SUB>0</SUB> (Eq. 19)
where D is the diffusion coefficient; cb and cs are bulk concentration and surface concentration, respectively; and delta  is the thickness of the diffusion layer. Here, the diffusion layer is an imaginary layer, which is used to convert the concentration gradient dc/dr on the RBC membrane into a simple fraction (cb - cs)/delta . Thus, the thickness of the diffusion layer is always related to the concentration gradient on a given surface. In a competition experiment, NO is generated around each RBC, so the diffusion layer is a layer within the unstirred layer around each RBC. In a blood vessel, the shape of the diffusion layer is much different. The blood flow creates an RBC-free layer near the vessel wall and increased concentration of RBCs near the center of the vessel like a flowing RBC cylinder (7, 10, 11). The endothelium-derived NO needs to diffuse across the RBC-free layer to reach RBCs. In this case, the diffusion layer is a layer within the RBC-free layer surrounding the surface of the flowing RBC cylinder. The diffusion layer can reduce NO uptake by RBCs and enhance the effective NO diffusion distance in the vessel wall (10).

Finally, we point out that numerous previous studies with erythrocytes do not support the possibility that it possesses an inherent diffusion barrier to small nonelectrolytes, certainly not of the magnitude proposed by Vaughn et al. (13, 14). The red cell membrane is 40% lipid, which represents a substantial surface of rapid access of NO for diffusion. The lipid bilayer is highly unlikely to possess such a barrier property, since the passive permeability of the RBC to nonelectrolytes is very similar to artificial lipid vesicles (and also other cell types) (31), and the permeability characteristics of lipid vesicles made from whole erythrocyte membrane lipids is quantitatively the same as for synthetic lipids (32). Also, the rate of lateral diffusion of NO in the red cell membrane is similar to phosphatidylcholine vesicles (33). O2 diffusion through thin films of erythrocytes is similar to that through equivalent thicknesses of free hemoglobin, indicating that the membrane possesses no barrier (34). The presence of the complex cytoskeletal network of the erythrocyte and/or binding of hemoglobin to the cytoskeleton also exerts no influence, since the passive permeability of intact red cells to mannitol and erythritol is the same as inside-out vesicles, which lack this cytoskeleton (35). In addition, if the cytoskeletal network serves as a physical barrier, in order to account for a retardation in entry of a factor of 800 (36) this mechanism would require that such a network would cover all but 1/800 = 0.125% of the total inner surface area of the membrane. The spectrin component is an elongated rod that forms a web with large spaces inbetween (37). As suggested by Huang et al. (36), hemoglobin could bind to the membrane and conceivably cover parts of the surface. However, with 106 hemoglobin molecules bound to band 3 per erythrocyte (38) and the size of hemoglobin at 64 × 55 × 50 Å3 (39), it can be calculated that the maximum surface area covered by the bound hemoglobin will be 45.7 µm2, whereas the total erythrocyte surface area is 135 µm2 (40). This would not explain a slowing of transmembrane NO movement of nearly 1000-fold.

In conclusion, the process of NO transfer into RBCs is of critical biological importance as it regulates the bioavailability and diffusion distance of endothelial derived NO. Our analysis shows that with increasing hematocrit, the distribution of NO concentration becomes more inhomogeneous rather than more homogeneous. Competition experiments did not eliminate extracellular diffusion resistance in measuring the ratio of kRBC/kHb under the reported experimental conditions. The rate of NO uptake by RBCs in competition experiments is primarily limited by extracellular diffusion not membrane resistance. The extremely low membrane permeability suggested by Vaughn et al. (14) is not only in conflict with many previous experimental results about O2 and NO uptake by RBCs, but also inconsistent with their results about the ratio of kRBC/kHb calculated from the competition equation.

    ACKNOWLEDGEMENT

We thank Dr. John S. Olson for helpful discussions.

    FOOTNOTES

* This work was supported by an American Heart Association Scientist Development Grant (to X. L.) and National Institutes of Health Grants HL38324, HL63744, and HL65608 (to J. L. Z.) and DK46935 (to J. R. L.).The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

§ To whom correspondence should be addressed: The EPR Center, Johns Hopkins Asthma and Allergy Center, 5501 Hopkins Bayview Circle, Rm. LA-14, Baltimore, MD 21224. Tel.: 410-550-0339; E-mail: xpliu@mail.jhmi.edu.

Published, JBC Papers in Press, May 10, 2002, DOI 10.1074/jbc.M201939200

    ABBREVIATIONS

The abbreviations used are: Hb, hemoglobin; RBC, red blood cell; Hct, hematocrit; Mb, myoglobin.

    REFERENCES
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES

1. Vallance, P., Collier, J., and Moncada, S. (1989) Lancet 2, 997-1000[Medline] [Order article via Infotrieve]
2. Lancaster, J. R., Jr. (1994) Proc. Natl. Acad. Sci. U. S. A. 91, 8137-8141[Abstract/Free Full Text]
3. Wood, J., and Garthwaite, J. (1994) Neuropharmacology 33, 1235-1244[CrossRef][Medline] [Order article via Infotrieve]
4. Eich, R. F., Li, T., Lemon, D. D., Doherty, D. H., Curry, S. R., Aitken, J. F., Mathews, A. J., Johnson, K. A., Smith, R. D., Phillips, G. N., Jr., and Olson, J, S. (1996) Biochemistry 35, 6976-6983[CrossRef][Medline] [Order article via Infotrieve]
5. Herold, S., Exner, M., and Nauser, T. (2001) Biochemistry 40, 3385-3395[CrossRef][Medline] [Order article via Infotrieve]
6. Martin, W., Villani, G. M., Jothianandan, D., and Furchgott, R. F. (1985) J. Pharmacol. Exp. Ther. 232, 708-716[Abstract/Free Full Text]
7. Liao, J. C., Hein, T. W., Vaughn, M. W., Huang, K. T., and Kuo, L. (1999) Proc. Natl. Acad. Sci. U. S. A. 96, 8757-8761[Abstract/Free Full Text]
8. Lancaster, J. R., Jr. (1997) Nitric Oxide 1, 18-30[CrossRef][Medline] [Order article via Infotrieve]
9. Liu, X., Miller, M. J., Joshi, M. S., Sadowska-Krowicka, H., Clark, D. A., and Lancaster, J. R., Jr. (1998) J. Biol. Chem. 273, 18709-18713[Abstract/Free Full Text]
10. Vaughn, M. W., Kuo, L., and Liao, J. C. (1998) Am. J. Physiol. 274, H1705-H1714
11. Butler, A. R., Megson, I. L., and Wright, P. G. (1998) Biochim. Biophys. Acta 1425, 168-176[Medline] [Order article via Infotrieve]
12. Gow, A. J., Luchsinger, B. P., Pawloski, J. R., Singel, D. J., and Stamler, J. S. (1999) Proc. Natl. Acad. Sci. U. S. A. 96, 9027-9032[Abstract/Free Full Text]
13. Vaughn, M. W., Huang, K. T., Kuo, L., and Liao, J. C. (2000) J. Biol. Chem. 275, 2342-2348[Abstract/Free Full Text]
14. Vaughn, M. W., Huang, K. T., Kuo, L., and Liao, J. C. (2001) Nitric Oxide 5, 18-31[CrossRef][Medline] [Order article via Infotrieve].,
15. Hartridge, H., and Roughton, F. J. W. (1927) J. Physiol. 62, 232-242.,
16. Nicholson, P., and Roughton, F. J. W. (1951) Proc. R. Soc. B 138, 241-264[Medline] [Order article via Infotrieve]
17. Holland, R. A. (1967) Respir. Physiol. 3, 307-317[CrossRef][Medline] [Order article via Infotrieve]
18. Coin, J. T., and Olson, J. S. (1979) J. Biol. Chem. 254, 1178-1190[Abstract/Free Full Text]
19. Rice, S. A. (1980) Biophys. J. 29, 65-77[Medline] [Order article via Infotrieve]
20. Kutchai, H. (1975) Respir. Physiol. 23, 121-132[CrossRef][Medline] [Order article via Infotrieve]
21. Shibuya, I., Niizeki, K., and Kagawa, T. (1988) Adv. Exp. Med. Biol. 222, 219-229[Medline] [Order article via Infotrieve]
22. Merchuk, J. C., Tzur, Z., and Lightfoot, E. N. (1983) Chem. Eng. Sci. 38, 1315-1321[CrossRef]
23. Vandegriff, K. D., and Olson, J. S (1984) Biophys. J. 45, 825-835[Medline] [Order article via Infotrieve]
24. Lide, D. R. (1990-1991) Handbook of chemistry and physics , 71st Ed. , pp. 6-151, CRC Press, Boca Raton, FL
25. Wilke, C. R., and Chang, P. (1955) AIChE J. 1, 264-270[CrossRef]
26. Lide, D. R. (1999-2000) Handbook of chemistry and physics , 80th Ed. , pp. 6-190, CRC Press, Boca Raton, FL
27. Cassoly, R., and Gibson, Q. (1975) J. Mol. Biol. 91, 301-313[CrossRef][Medline] [Order article via Infotrieve]
28. Subczynski, W. K., Lomnicka, M., and Hyde, J. S. (1996) Free Radic. Res. 24, 343-349[Medline] [Order article via Infotrieve]
29. Huxley, V. H., and Kutchai, H. (1981) J. Physiol. 316, 75-83[Abstract/Free Full Text]
30. Vandegriff, K. D., and Olson, J. S. (1984) J. Biol. Chem. 259, 12619-12627[Abstract/Free Full Text]
31. Weiss, T. F. (1996) Cellular Biophysics , Vol. I , p. 149, MIT Press, Cambridge, MA
32. Carruthers, A., and Melchior, D. L. (1983) Biochemistry 22, 5797-5807[CrossRef]
33. Denicola, A., Souza, J. M., Radi, R., and Lissi, E. (1996) Arch. Biochem. Biophys. 328, 208-212[CrossRef][Medline] [Order article via Infotrieve]
34. Kutchai, H., and Staub, N. C. (1969) J. Gen. Physiol. 53, 576-589[Abstract/Free Full Text]
35. Klonk, S., and Deuticke, B. (1992) Biochim. Biophys. Acta 1106, 143-150[Medline] [Order article via Infotrieve]
36. Huang, K. T., Vaughn, M. W., Hyduke, D. R., Van Herle, H., Hein, T. W., Zhang, C., Kuo, L., and Liao, J. C. (2001) Proc. Natl. Acad. Sci. U. S. A. 98, 11771-11776[Abstract/Free Full Text]
37. Ursitti, J. A., Pumplin, D. W., Wade, J. B., and Bloch, R. J. (1991) Cell Motil. Cytoskel. 19, 227-243[CrossRef][Medline] [Order article via Infotrieve]
38. Shaklai, N., Yguerabide, J., and Ranney, H. M. (1977) Biochemistry 16, 5593-5597[CrossRef][Medline] [Order article via Infotrieve]
39. Voet, D., and Voet, J. G. (1995) Biochemistry , 2nd Ed. , p. 224, John Wiley and Sons, New York
40. Evans, E., and Fung, Y. C. (1972) Microvasc. Res. 4, 335-347[CrossRef][Medline] [Order article via Infotrieve]


Copyright © 2002 by The American Society for Biochemistry and Molecular Biology, Inc.
Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
P. C. Minneci, K. J. Deans, S. Shiva, H. Zhi, S. M. Banks, S. Kern, C. Natanson, S. B. Solomon, and M. T. Gladwin
Nitrite reductase activity of hemoglobin as a systemic nitric oxide generator mechanism to detoxify plasma hemoglobin produced during hemolysis
Am J Physiol Heart Circ Physiol, August 1, 2008; 295(2): H743 - H754.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Cell Physiol.Home page
J. Zhu, S. Li, Z. M. Marshall, and A. R. Whorton
A cystine-cysteine shuttle mediated by xCT facilitates cellular responses to S-nitrosoalbumin
Am J Physiol Cell Physiol, April 1, 2008; 294(4): C1012 - C1020.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
H. Sakai, A. Sato, K. Masuda, S. Takeoka, and E. Tsuchida
Encapsulation of Concentrated Hemoglobin Solution in Phospholipid Vesicles Retards the Reaction with NO, but Not CO, by Intracellular Diffusion Barrier
J. Biol. Chem., January 18, 2008; 283(3): 1508 - 1517.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
X. Liu, Q. Yan, K. L. Baskerville, and J. L. Zweier
Estimation of Nitric Oxide Concentration in Blood for Different Rates of Generation: EVIDENCE THAT INTRAVASCULAR NITRIC OXIDE LEVELS ARE TOO LOW TO EXERT PHYSIOLOGICAL EFFECTS
J. Biol. Chem., March 23, 2007; 282(12): 8831 - 8836.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Renal Physiol.Home page
W. Zhang and A. Edwards
A model of nitric oxide tubulovascular cross talk in a renal outer medullary cross section
Am J Physiol Renal Physiol, February 1, 2007; 292(2): F711 - F722.
[Abstract] [Full Text] [PDF]


Home page
J. Physiol.Home page
C. N. Hall and J. Garthwaite
Inactivation of nitric oxide by rat cerebellar slices
J. Physiol., December 1, 2006; 577(2): 549 - 567.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
B. C. Kone
NO Break-Ins at Water Gate
Hypertension, July 1, 2006; 48(1): 29 - 30.
[Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
D. B. Kim-Shapiro, A. N. Schechter, and M. T. Gladwin
Unraveling the Reactions of Nitric Oxide, Nitrite, and Hemoglobin in Physiology and Therapeutics
Arterioscler. Thromb. Vasc. Biol., April 1, 2006; 26(4): 697 - 705.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
A. Rebel, S. Cao, H. Kwansa, S. Dore, E. Bucci, and R. C. Koehler
Dependence of acetylcholine and ADP dilation of pial arterioles on heme oxygenase after transfusion of cell-free polymeric hemoglobin
Am J Physiol Heart Circ Physiol, March 1, 2006; 290(3): H1027 - H1037.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
M. Kavdia and A. S. Popel
Venular endothelium-derived NO can affect paired arteriole: a computational model
Am J Physiol Heart Circ Physiol, February 1, 2006; 290(2): H716 - H723.
[Abstract] [Full Text] [PDF]


Home page
J. Appl. Physiol.Home page
X. Qin, H. Kwansa, E. Bucci, R. J. Roman, and R. C. Koehler
Role of 20-HETE in the pial arteriolar constrictor response to decreased hematocrit after exchange transfusion of cell-free polymeric hemoglobin
J Appl Physiol, January 1, 2006; 100(1): 336 - 342.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
I. Azarov, K. T. Huang, S. Basu, M. T. Gladwin, N. Hogg, and D. B. Kim-Shapiro
Nitric Oxide Scavenging by Red Blood Cells as a Function of Hematocrit and Oxygenation
J. Biol. Chem., November 25, 2005; 280(47): 39024 - 39032.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
K. Sampei, J. A. Ulatowski, Y. Asano, H. Kwansa, E. Bucci, and R. C. Koehler
Role of nitric oxide scavenging in vascular response to cell-free hemoglobin transfusion
Am J Physiol Heart Circ Physiol, September 1, 2005; 289(3): H1191 - H1201.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
A. Philippides, S. R. Ott, P. Husbands, T. A. Lovick, and M. O'Shea
Modeling Cooperative Volume Signaling in a Plexus of Nitric Oxide Synthase-Expressing Neurons
J. Neurosci., July 13, 2005; 25(28): 6520 - 6532.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
J. O. Lundberg and E. Weitzberg
NO Generation From Nitrite and Its Role in Vascular Control
Arterioscler. Thromb. Vasc. Biol., May 1, 2005; 25(5): 915 - 922.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
K. Tsuchiya, Y. Kanematsu, M. Yoshizumi, H. Ohnishi, K. Kirima, Y. Izawa, M. Shikishima, T. Ishida, S. Kondo, S. Kagami, et al.
Nitrite is an alternative source of NO in vivo
Am J Physiol Heart Circ Physiol, May 1, 2005; 288(5): H2163 - H2170.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
N. M. Tsoukias, M. Kavdia, and A. S. Popel
A theoretical model of nitric oxide transport in arterioles: frequency- vs. amplitude-dependent control of cGMP formation
Am J Physiol Heart Circ Physiol, March 1, 2004; 286(3): H1043 - H1056.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
K. W. Raines, G.-L. Cao, S. Porsuphatana, P. Tsai, G. M. Rosen, and P. Shapiro
Nitric Oxide Inhibition of ERK1/2 Activity in Cells Expressing Neuronal Nitric-oxide Synthase
J. Biol. Chem., February 6, 2004; 279(6): 3933 - 3940.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
X. Xu, M. Cho, N. Y. Spencer, N. Patel, Z. Huang, H. Shields, S. B. King, M. T. Gladwin, N. Hogg, and D. B. Kim-Shapiro
Measurements of nitric oxide on the heme iron and {beta}-93 thiol of human hemoglobin during cycles of oxygenation and deoxygenation
PNAS, September 30, 2003; 100(20): 11303 - 11308.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
J. H. Crawford, C. R. White, and R. P. Patel
Vasoactivity of S-nitrosohemoglobin: role of oxygen, heme, and NO oxidation states
Blood, June 1, 2003; 101(11): 4408 - 4415.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
P. Condorelli and S. C. George
Free nitric oxide diffusion in the bronchial microcirculation
Am J Physiol Heart Circ Physiol, December 1, 2002; 283(6): H2660 - H2670.
[Abstract] [Full Text] [PDF]


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
277/29/26194    most recent
M201939200v1
Right arrow Submit a Letter to Editor
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Liu, X.
Right arrow Articles by Zweier, J. L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Liu, X.
Right arrow Articles by Zweier, J. L.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 All ASBMB Journals   Molecular and Cellular Proteomics 
 Journal of Lipid Research   ASBMB Today 
Copyright © 2002 by the American Society for Biochemistry and Molecular Biology.
Advertisement
spacer
Advertisement
Advertisement